GoHealth, Inc. (NASDAQ:GOCO) Given Consensus Rating of “Buy” by Brokerages

GoHealth, Inc. (NASDAQ:GOCO) has received an average rating of “Buy” from the twelve analysts that are presently covering the stock, MarketBeat Ratings reports. One research analyst has rated the stock with a sell rating, one has given a hold rating and ten have issued a buy rating on the company. The average 12 month price objective among analysts that have issued ratings on the stock in the last year is $21.63.

GOCO has been the subject of several research reports. Morgan Stanley lowered their price objective on shares of GoHealth from $18.00 to $14.00 and set an “equal weight” rating for the company in a research note on Thursday, November 12th. Raymond James reissued a “buy” rating on shares of GoHealth in a research note on Thursday, November 12th. Zacks Investment Research cut shares of GoHealth from a “hold” rating to a “sell” rating in a research note on Tuesday, January 12th. Evercore ISI decreased their price target on shares of GoHealth from $27.00 to $25.00 and set an “outperform” rating for the company in a research report on Thursday, November 12th. Finally, Credit Suisse Group decreased their price target on shares of GoHealth from $25.00 to $21.00 and set an “outperform” rating for the company in a research report on Monday, November 16th.

GOCO traded down $0.38 during trading on Monday, hitting $14.00. The company’s stock had a trading volume of 1,620,945 shares, compared to its average volume of 1,372,704. The firm’s 50 day moving average price is $14.42 and its 200-day moving average price is $13.86. GoHealth has a twelve month low of $10.01 and a twelve month high of $26.25.

GoHealth (NASDAQ:GOCO) last announced its quarterly earnings data on Wednesday, November 11th. The company reported $1.82 earnings per share (EPS) for the quarter. The company had revenue of $163.36 million for the quarter, compared to analysts’ expectations of $168.12 million. As a group, equities research analysts forecast that GoHealth will post -0.28 earnings per share for the current fiscal year.

In other GoHealth news, COO Shane E. Cruz sold 11,829 shares of the business’s stock in a transaction on Wednesday, January 27th. The shares were sold at an average price of $15.02, for a total value of $177,671.58. Following the transaction, the chief operating officer now owns 75,000 shares in the company, valued at approximately $1,126,500. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, CFO Travis J. Matthiesen sold 146,000 shares of the company’s stock in a transaction dated Monday, January 11th. The shares were sold at an average price of $14.98, for a total transaction of $2,187,080.00. Following the completion of the sale, the chief financial officer now owns 146,000 shares in the company, valued at approximately $2,187,080. The disclosure for this sale can be found here. Insiders sold a total of 232,829 shares of company stock worth $3,462,752 in the last quarter.

Institutional investors have recently modified their holdings of the company. Blair William & Co. IL acquired a new stake in shares of GoHealth in the 3rd quarter valued at about $294,000. Morgan Stanley acquired a new stake in shares of GoHealth in the 3rd quarter valued at about $1,059,000. Schonfeld Strategic Advisors LLC acquired a new stake in shares of GoHealth in the 3rd quarter valued at about $735,000. California Public Employees Retirement System acquired a new stake in shares of GoHealth in the 3rd quarter valued at about $1,296,000. Finally, Treasurer of the State of North Carolina acquired a new stake in shares of GoHealth in the 3rd quarter valued at about $198,000. Institutional investors and hedge funds own 26.55% of the company’s stock.

GoHealth Company Profile

As a leading health insurance marketplace, GoHealth's mission is to improve access to healthcare in America. Enrolling in a health insurance plan can be confusing for customers, and the seemingly small differences between plans can lead to significant out-of-pocket costs or lack of access to critical medicines and even providers.

Further Reading: Understanding the two types of arbitrage

Analyst Recommendations for GoHealth (NASDAQ:GOCO)

Receive News & Ratings for GoHealth Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for GoHealth and related companies with MarketBeat.com's FREE daily email newsletter.

Comments


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on reddit